KEAP1 and cancer: NRF2 activation in cancer cells is closely related to multiple pathways, such as NRF2 gene mutation leading to overactivation of NRF2 in cancer cells; P62 accumulation competes with NRF2 to bind Keap1 to that NRF2 accumulates in tumor cells.